{
    "N/R/U": null,
    "Applicant": "Sandoz Inc.",
    "BLA Number": "125553",
    "Proprietary Name": "Zarxio",
    "Proper Name": "filgrastim-sndz",
    "BLA Type": "351(k) Biosimilar",
    "Strength": "480MCG/1.6ML (300MCG/ML)",
    "Dosage Form": "Injection ",
    "Route of Administration": "Intravenous, Subcutaneous ",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Disc",
    "Licensure": "Licensed",
    "Approval Date": "August 09, 2024",
    "Ref. Product Proper Name": "filgrastim",
    "Ref. Product Proprietary Name": "Neupogen",
    "Supplement Number": "32",
    "Submission Type": "Supplement",
    "License Number": "2003",
    "Product Number": "004",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null,
    "drug": [
        {
            "name": "filgrastim-sndz",
            "drugbank_id": "https://go.drugbank.com/drugs/DB00099"
        }
    ]
}